Gilcrease M Z, Schmidt L, Zbar B, Truong L, Rutledge M, Wheeler T M
Department of Pathology, Baylor College of Medicine, Houston, TX, USA.
Hum Pathol. 1995 Dec;26(12):1341-6. doi: 10.1016/0046-8177(95)90299-6.
Papillary cystadenoma of the epididymis is an uncommon benign lesion that may occur sporadically or as a manifestation of von Hippel-Lindau (VHL) disease. Neither immunohistochemical studies nor molecular genetic analyses of the VHL gene have been reported previously for this lesion. The authors describe two cases of clear cell papillary cystadenoma of the epididymis, both of which were initially confused with metastatic renal cell carcinoma. Both lesions showed positive immunohistochemical staining for low and intermediate molecular weight keratins (Cam 5.2 and AE1/AE3), EMA, vimentin, alpha 1-antitrypsin, and alpha 1-antichymotrypsin. Each was negative for CEA. Because clear cell papillary cystadenoma is similar to renal cell carcinoma histologically, and because both occur as components of the von Hippel-Lindau disease complex, the authors analyzed both cases for the presence of mutations in the VHL gene. A somatic VHL gene mutation was detected in one of the two tumors by polymerase chain reaction followed by single-strand conformation polymorphism analysis. Direct sequencing revealed a cytosine to thymine transition at nucleotide 694, resulting in the replacement of an arginine with a stop codon after the sixth amino acid of exon 3. As the VHL gene is believed to function as a tumor suppressor gene, VHL gene mutations may play a role in the initiation of tumorigenesis in sporadic cystadenomas of the epididymis.
附睾乳头状囊腺瘤是一种罕见的良性病变,可散发性发生或作为冯·希佩尔-林道(VHL)病的一种表现。此前尚未有关于该病变的免疫组织化学研究或VHL基因的分子遗传学分析报道。作者描述了两例附睾透明细胞乳头状囊腺瘤病例,这两例最初都被误诊为转移性肾细胞癌。两种病变均显示低分子量和中分子量角蛋白(Cam 5.2和AE1/AE3)、上皮膜抗原(EMA)、波形蛋白、α1-抗胰蛋白酶和α1-抗糜蛋白酶免疫组织化学染色呈阳性。癌胚抗原(CEA)均为阴性。由于透明细胞乳头状囊腺瘤在组织学上与肾细胞癌相似,且二者均作为冯·希佩尔-林道病复合体的组成部分出现,作者对这两例病例进行了VHL基因突变检测。通过聚合酶链反应及单链构象多态性分析,在其中一个肿瘤中检测到了VHL基因的体细胞突变。直接测序显示在核苷酸694处胞嘧啶突变为胸腺嘧啶,导致第3外显子第6个氨基酸后的精氨酸被终止密码子取代。由于VHL基因被认为具有肿瘤抑制基因的功能,VHL基因突变可能在散发性附睾囊腺瘤的肿瘤发生起始过程中发挥作用。